ArticleFrontiers in pharmacology2026

Decoding FGFR inhibitor sensitivity in cholangiocarcinoma with interpretable machine learning and cross-platform pharmacogenomic validation.

Yading Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.